Pfizer
American multinational pharmaceutical and biotechnology corporation
PFE NYSE
ISIN US7170811035 SEC CIK 78003 LEI 765LHXWGK1KXCLTFYQ30
Follow Pfizer
Weekly email: filings, results
Revenue, last quarter
$16.6B
−0.4% vs same quarter last year
Net income
$3.2B
−8.4% vs same quarter last year
EPS, diluted
$0.56
−9.7% vs same quarter last year
Operating cash flow
$5.4B
+16.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $62.6B | $7.8B |
| FY24 | $63.6B | $8B |
| FY23 | $50.9B | $2.1B |
| FY22 | $91.8B | $31.4B |
| FY21 | $73.6B | $22B |
| FY20 | $41.7B | $9.2B |
| FY19 | $40.9B | $16B |
| FY18 | $40.8B | $11.2B |
| FY17 | $52.5B | $21.3B |
| FY16 | $52.8B | $7.2B |
| FY15 | $48.9B | $7B |
| FY14 | $49.6B | $9.1B |
| FY13 | $51.6B | $22B |
| FY12 | $54.7B | $14.6B |
| FY11 | $61B | $10B |
- Gross margin
- Net margin
Show the numbers
| Year | Gross margin | Net margin |
|---|---|---|
| FY25 | 74.3% | 12.4% |
| FY24 | 71.9% | 12.6% |
| FY23 | 51% | 4.2% |
| FY22 | 62.6% | 34.2% |
| FY21 | 58.1% | 29.8% |
| FY20 | 79.6% | 22% |
| FY19 | 80.3% | 39.2% |
| FY18 | 78% | 27.3% |
| FY17 | 78.6% | 40.6% |
| FY16 | 76.7% | 13.7% |
| FY15 | 80.3% | 14.2% |
| FY14 | 80.7% | 18.4% |
| FY13 | 81.4% | 42.7% |
| FY12 | 82% | 26.7% |
| FY11 | 79.5% | 16.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $9.1B |
| FY24 | $9.8B |
| FY23 | $4.8B |
| FY22 | $26B |
| FY21 | $29.9B |
| FY20 | $12.2B |
| FY19 | $10.5B |
| FY18 | $13.8B |
| FY17 | $14.8B |
| FY16 | $14.4B |
| FY15 | $13.3B |
| FY14 | $15.9B |
| FY13 | $16.5B |
| FY12 | $15.4B |
| FY11 | $18.6B |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | $0 |
| FY23 | $0 |
| FY22 | $2B |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | $8.9B |
| FY18 | $12.2B |
| FY17 | $5B |
| FY16 | $5B |
| FY15 | $6.2B |
| FY14 | $5B |
| FY13 | $16.3B |
| FY12 | $8.2B |
| FY11 | $9B |
- Pfizer
- Healthcare median
Show the numbers
| Year | Pfizer | Healthcare median |
|---|---|---|
| FY25 | 12.4% | −30.6% |
| FY24 | 12.6% | −47% |
| FY23 | 4.2% | −58% |
| FY22 | 34.2% | −80.4% |
| FY21 | 29.8% | −71.9% |
| FY20 | 22% | −62.2% |
| FY19 | 39.2% | −46.3% |
| FY18 | 27.3% | −49.6% |
| FY17 | 40.6% | −45.9% |
| FY16 | 13.7% | −36% |
| FY15 | 14.2% | −38.4% |
| FY14 | 18.4% | −35.5% |
| FY13 | 42.7% | −37.1% |
| FY12 | 26.7% | −29.1% |
| FY11 | 16.4% | −27.9% |